Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2009;40:762-766
Published online before print January 8, 2009, doi: 10.1161/STROKEAHA.108.522516
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
40/3/762    most recent
STROKEAHA.108.522516v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Quinn, T. J.
Right arrow Articles by Lees, K. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Quinn, T. J.
Right arrow Articles by Lees, K. R.
Related Collections
Right arrow Health policy and outcome research
Right arrow Acute Cerebral Infarction

(Stroke. 2009;40:762.)
© 2009 American Heart Association, Inc.


Original Contributions

Exploring the Reliability of the Modified Rankin Scale

Terence J. Quinn, MRCP; Jesse Dawson, MRCP; Matthew R. Walters, MD Kennedy R. Lees, MD

From the Department Cardiovascular and Medical Sciences, Faculty of Medicine, University of Glasgow, Glasgow, UK.

Correspondence to Terence J. Quinn, MRCP, Gardiner Institute of Cardiovascular and Medical Sciences, Western Infirmary, Glasgow G11 6NT, UK. E-mail Tjq1t{at}clinmed.gla.ac

Background and Purpose— The modified Rankin Scale (mRS) is the most prevalent outcome measure in stroke trials. Use of the mRS may be hampered by variability in grading. Previous estimates of the properties of the mRS have used diverse methodologies and may not apply to contemporary trial populations. We used a mock clinical trial design to explore inter- and intraobserver variability of the mRS.

Methods— Consenting patients with stroke attending for outpatient review had the mRS performed by 2 independent assessors with pairs of assessors selected from a team of 3 research nurses and 4 stroke physicians. Before formal assessment, interviewers estimated disability based only on initial patient observation. Each patient was then randomized to undergo the mRS using standard assessment or a prespecified structured interview. The second interviewer in the pair reassessed the patient using the same method blinded to the colleague’s score. For each patient assessed, one rater was randomly assigned to video record their interview. After 3 months, this interviewer reviewed and regraded their original video assessment.

Results— Across 100 paired assessments, interobserver agreement was moderate (k=0.57). Intraobserver variability was good (k=0.72) but less than would be expected from previous literature. Forty-nine assessments were performed using the structured interview approach with no significant difference between structured and standard mRS. Researchers were unable to reliably predict mRS from initial limited patient assessment (k=0.16).

Conclusions— Despite availability of training and structured interview, there remains substantial interobserver variability in mRS grades awarded even by experienced researchers. Additional methods to improve mRS reliability are required.


Key Words: clinical trials • clinometrics • modified Rankin Scale • outcome assessment • stroke • stroke treatment • video recording




This article has been cited by other articles:


Home page
StrokeHome page
T. J. Quinn, J. Dawson, M. R. Walters, and K. R. Lees
Reliability of the Modified Rankin Scale: A Systematic Review
Stroke, October 1, 2009; 40(10): 3393 - 3395.
[Abstract] [Full Text] [PDF]